Cargando…

Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting

SUMMARY: Osteoporosis represents a significant and increasing healthcare burden in Europe, but most patients at increased risk of fracture do not receive medication, resulting in a large treatment gap. Identification of patients who are at particularly high risk will help clinicians target appropria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanis, J. A., Cooper, C., Rizzoli, R., Abrahamsen, B., Al-Daghri, N. M., Brandi, M. L., Cannata-Andia, J., Cortet, B., Dimai, H. P., Ferrari, S., Hadji, P., Harvey, N. C., Kraenzlin, M., Kurth, A., McCloskey, E., Minisola, S., Thomas, T., Reginster, J.-Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483332/ https://www.ncbi.nlm.nih.gov/pubmed/28451733 http://dx.doi.org/10.1007/s00198-017-4009-0

Ejemplares similares

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
por: Hiligsmann, M., et al.
Publicado: (2019)

Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art—outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Diez-Perez, Adolfo, et al.
Publicado: (2019)

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
por: Hadji, Peyman, et al.
Publicado: (2017)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation
por: Hiligsmann, M., et al.
Publicado: (2018)

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
por: Ferrari, Serge, et al.
Publicado: (2016)

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Moon, Rebecca J., et al.
Publicado: (2023)

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J. A., et al.
Publicado: (2019)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J. A., et al.
Publicado: (2012)

Vitamin D status correction in Saudi Arabia: an experts’ consensus under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO)
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
por: Kanis, J.A., et al.
Publicado: (2020)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group
por: Chevalley, Thierry, et al.
Publicado: (2022)

How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
por: Chevalley, T., et al.
Publicado: (2021)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Management of patients at very high risk of osteoporotic fractures through sequential treatments
por: Curtis, Elizabeth M., et al.
Publicado: (2022)

Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults
por: Reginster, Jean-Yves, et al.
Publicado: (2020)

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: de Wit, Maarten, et al.
Publicado: (2019)

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
por: McCloskey, E. V., et al.
Publicado: (2019)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging
por: Shevroja, Enisa, et al.
Publicado: (2023)

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N. R., et al.
Publicado: (2021)

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
por: Rozenberg, S., et al.
Publicado: (2020)

Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
por: Fuggle, N.R., et al.
Publicado: (2021)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study
por: McCloskey, E., et al.
Publicado: (2020)

Osteoporosis management in hematologic stem cell transplant recipients: Executive summary
por: Kendler, D.L., et al.
Publicado: (2021)

Alternative and complementary therapies in osteoarthritis and cartilage repair
por: Fuggle, N. R., et al.
Publicado: (2020)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2018)

Correction to: European guidance for the diagnosis and management of osteoporosis in postmenopausal women
por: Kanis, J.A., et al.
Publicado: (2020)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment
por: Beaudart, C., et al.
Publicado: (2022)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – the “Wco-iof-esceo Congress”: The 18th edition of the WCO-IOF-ESCEO Congress – Krakow 2018
por: Maślińska, Maria
Publicado: (2018)

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
por: Fuggle, N. R., et al.
Publicado: (2020)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
por: Rizzoli, R., et al.
Publicado: (2010)

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Meet-The-Experts Abstracts
Publicado: (2022)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_153u08h3ari176fiehmjvhqn8r